Michael Borenstein

43.0k total citations · 10 hit papers
97 papers, 26.4k citations indexed

About

Michael Borenstein is a scholar working on Psychiatry and Mental health, Statistics, Probability and Uncertainty and Statistics and Probability. According to data from OpenAlex, Michael Borenstein has authored 97 papers receiving a total of 26.4k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Psychiatry and Mental health, 14 papers in Statistics, Probability and Uncertainty and 9 papers in Statistics and Probability. Recurrent topics in Michael Borenstein's work include Schizophrenia research and treatment (25 papers), Meta-analysis and systematic reviews (14 papers) and Statistical Methods in Clinical Trials (5 papers). Michael Borenstein is often cited by papers focused on Schizophrenia research and treatment (25 papers), Meta-analysis and systematic reviews (14 papers) and Statistical Methods in Clinical Trials (5 papers). Michael Borenstein collaborates with scholars based in United States, United Kingdom and Germany. Michael Borenstein's co-authors include Hannah R. Rothstein, Julian P. T. Higgins, Larry V. Hedges, Alex J. Sutton, John M. Kane, Jacob Cohen, J.A. Lieberman, Taishiro Kishimoto, Christoph U. Correll and Manzar Ashtari and has published in prestigious journals such as American Journal of Psychiatry, Biological Psychiatry and Annals of the New York Academy of Sciences.

In The Last Decade

Michael Borenstein

96 papers receiving 25.7k citations

Hit Papers

Introduction to Meta‐Analysis 1994 2026 2004 2015 2009 2010 2021 2005 2017 2.5k 5.0k 7.5k 10.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Introduction to Meta‐Analysis
    2009 10.6k citations Michael Borenstein, Larry V. Hedges et al. profile →
  2. A basic introduction to fixed-effect and random-effects models for meta-analysis
    2010 5.0k citations Michael Borenstein, Larry V. Hedges et al. Research Synthesis Methods profile →
  3. Introduction to Meta‐Analysis
    2021 1.9k citations Michael Borenstein, Larry V. Hedges et al. profile →
  4. Publication Bias in Meta‐Analysis
    2005 1.9k citations Hannah R. Rothstein, Alex J. Sutton et al. profile →
  5. Basics of meta‐analysis: I2 is not an absolute measure of heterogeneity
    2017 1.3k citations Michael Borenstein, Julian P. T. Higgins et al. Research Synthesis Methods profile →
  6. Meta-Analysis and Subgroups
    2013 564 citations Michael Borenstein, Julian P. T. Higgins profile →
  7. Increase in caudate nuclei volumes of first-episode schizophrenic patients taking antipsychotic drugs
    1994 474 citations Michael Borenstein, Manzar Ashtari et al. profile →
  8. Effect sizes for continuous data.
    2009 428 citations Michael Borenstein profile →
  9. Development of the Instrument to assess the Credibility of Effect Modification Analyses (ICEMAN) in randomized controlled trials and meta-analyses
    2020 356 citations Michael Borenstein et al. profile →
  10. How to understand and report heterogeneity in a meta-analysis: The difference between I-squared and prediction intervals
    2023 77 citations Michael Borenstein profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Borenstein United States 40 4.1k 3.9k 2.3k 2.3k 2.1k 97 26.4k
Hannah R. Rothstein United States 24 4.3k 1.0× 1.7k 0.4× 3.3k 1.4× 1.9k 0.8× 2.2k 1.1× 53 25.9k
Domenic V. Cicchetti United States 59 6.8k 1.7× 3.3k 0.8× 2.3k 1.0× 6.0k 2.7× 1.8k 0.9× 188 24.7k
Robert F. DeVellis United States 51 4.6k 1.1× 2.5k 0.6× 3.8k 1.6× 2.3k 1.0× 1.3k 0.6× 164 27.3k
John Weinman United Kingdom 79 4.1k 1.0× 5.5k 1.4× 2.8k 1.2× 1.8k 0.8× 1.7k 0.8× 365 30.5k
Robert D. Gibbons United States 68 5.7k 1.4× 4.5k 1.2× 1.7k 0.7× 1.6k 0.7× 2.2k 1.1× 336 18.2k
James G. Scott United States 84 8.6k 2.1× 5.1k 1.3× 5.6k 2.4× 2.8k 1.2× 2.3k 1.1× 731 36.8k
Wolfgang Viechtbauer Netherlands 55 7.1k 1.7× 4.8k 1.2× 3.9k 1.7× 3.5k 1.5× 5.6k 2.7× 186 34.2k
Sue Duval United States 49 3.2k 0.8× 2.1k 0.5× 1.6k 0.7× 1.3k 0.6× 1.6k 0.8× 177 29.6k
Stef van Buuren Netherlands 54 3.4k 0.8× 1.8k 0.5× 1.6k 0.7× 902 0.4× 1.5k 0.7× 209 30.1k
Robert Stewart United Kingdom 85 5.6k 1.4× 8.1k 2.1× 2.9k 1.3× 1.7k 0.7× 2.2k 1.1× 848 30.2k

Countries citing papers authored by Michael Borenstein

Since Specialization
Citations

This map shows the geographic impact of Michael Borenstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Borenstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Borenstein more than expected).

Fields of papers citing papers by Michael Borenstein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Borenstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Borenstein. The network helps show where Michael Borenstein may publish in the future.

Co-authorship network of co-authors of Michael Borenstein

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Borenstein. A scholar is included among the top collaborators of Michael Borenstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Borenstein. Michael Borenstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kishimoto, Taishiro, Masahiro Nitta, Michael Borenstein, John M. Kane, & Christoph U. Correll. (2013). Long-Acting Injectable Versus Oral Antipsychotics in Schizophrenia. The Journal of Clinical Psychiatry. 74(10). 957–965. 339 indexed citations
2.
Borenstein, Michael, Larry V. Hedges, Julian P. T. Higgins, & Hannah R. Rothstein. (2010). A basic introduction to fixed-effect and random-effects models for meta-analysis. Research Synthesis Methods. 1(2). 97–111. 4956 indexed citations breakdown →
3.
Borenstein, Michael. (2009). Effect sizes for continuous data.. 428 indexed citations breakdown →
4.
Schoenfeld, David & Michael Borenstein. (2005). Calculating the power or sample size for the logistic and proportional hazards models. Journal of Statistical Computation and Simulation. 75(10). 771–785. 20 indexed citations
5.
Rothstein, Hannah R., Alex J. Sutton, & Michael Borenstein. (2005). Publication Bias in Meta‐Analysis. 1854 indexed citations breakdown →
6.
Borenstein, Michael, et al.. (2004). A reverse-phase HPLC and fluorescence detection method for measurement of 5-hydroxytryptamine (serotonin) in Planaria. Journal of Pharmacological and Toxicological Methods. 51(1). 73–76. 39 indexed citations
7.
Yue, Hongfei, et al.. (2004). Determination of bioactive eicosanoids in brain tissue by a sensitive reversed-phase liquid chromatographic method with fluorescence detection. Journal of Chromatography B. 803(2). 267–277. 50 indexed citations
8.
Stone, Dennis J., Michael Borenstein, Ellen E. Codd, et al.. (2001). Gas chromatographic method using nitrogen–phosphorus detection for the measurement of tramadol and its O-desmethyl metabolite in plasma and brain tissue of mice and rats. Journal of Chromatography B Biomedical Sciences and Applications. 763(1-2). 165–171. 46 indexed citations
9.
Kane, John M., Stephen R. Marder, Nina R. Schooler, et al.. (2001). Clozapine and Haloperidol in Moderately Refractory Schizophrenia. Archives of General Psychiatry. 58(10). 965–965. 139 indexed citations
10.
Aksoy, Mark O., et al.. (1999). Effects of topical corticosteroids on inflammatory mediator–induced eicosanoid release by human airway epithelial cells. Journal of Allergy and Clinical Immunology. 103(6). 1081–1091. 46 indexed citations
11.
Khandelwal, Meena, E. Albert Reece, Ying Wu, & Michael Borenstein. (1998). Dietary myo-inositol therapy in hyperglycemia-induced embryopathy. Teratology. 57(2). 79–84. 51 indexed citations
12.
Borenstein, Michael. (1997). Hypothesis Testing and Effect Size Estimation in Clinical Trials. Annals of Allergy Asthma & Immunology. 78(1). 5–16. 37 indexed citations
13.
Sivan, Eyal, E. Albert Reece, Ying-King Wu, et al.. (1996). Dietary vitamin E prophylaxis and diabetic embryopathy: Morphologic and biochemical analysis. American Journal of Obstetrics and Gynecology. 175(4). 793–799. 109 indexed citations
14.
Ashtari, Manzar, et al.. (1990). Computerized Volume Measurement of Brain Structure. Investigative Radiology. 25(7). 798–805. 76 indexed citations
15.
Cohen, Jacob & Michael Borenstein. (1988). Statistical power analysis : a computer program. 216 indexed citations
16.
Borenstein, Michael, et al.. (1987). Anticonvulsant Activity of Indanylspirosuccinimide Mannich Bases. Journal of Pharmaceutical Sciences. 76(4). 300–302. 20 indexed citations
17.
Kane, John M., Margaret G. Woerner, Michael Borenstein, James T. Wegner, & J.A. Lieberman. (1986). Integrating incidence and prevalence of tardive dyskinesia.. PubMed. 22(1). 254–8. 152 indexed citations
18.
Lieberman, Jeffrey A., Thomas B. Cooper, Raymond F. Suckow, et al.. (1986). Tricyclic Antidepressant Drug and Metabolite Levels in Chronic Renal Failure. Annals of the New York Academy of Sciences. 463(1). 304–306. 1 indexed citations
19.
Kane, John M., Michael Borenstein, & Margaret G. Woerner. (1984). Psychopharmacologic issues in the maintenance treatment of schizophrenia.. PubMed. 20(3). 423–5. 2 indexed citations
20.
Kane, John M., et al.. (1983). Safety and efficacy of bupropion in elderly patients: preliminary observations.. PubMed. 44(5 Pt 2). 134–6. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hannah R. Rothstein Breakdown of academic impact, for papers by Domenic V. Cicchetti Breakdown of academic impact, for papers by Robert F. DeVellis Breakdown of academic impact, for papers by John Weinman Breakdown of academic impact, for papers by Robert D. Gibbons Breakdown of academic impact, for papers by James G. Scott Breakdown of academic impact, for papers by Wolfgang Viechtbauer Breakdown of academic impact, for papers by Sue Duval Breakdown of academic impact, for papers by Stef van Buuren Breakdown of academic impact, for papers by Robert Stewart
Rankless by CCL
2026